Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivors

Blood. 1976 Oct;48(4):485-90.

Abstract

Eleven of twenty-four patients with severe aplastic anemia given marrow grafts from HLA-identical siblings between October 1970 and March 1973 are alive with normal marrow function and continued evidence of engraftment 3-5 yr later. Ten have been leading normal lives with no immunosuppressive or other drug therapy since day 100 postgrafting. One has had chronic graft-versus-host disease of the skin which is now slowly improving with no therapy. He returned to full-time employment in the summer of 1975. The long-term well-being of almost half of our initial patients emphasizes the importance of marrow transplantation for the treatment of severe aplastic anemia.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anemia, Aplastic / blood
  • Anemia, Aplastic / immunology
  • Anemia, Aplastic / therapy*
  • Bone Marrow Cells*
  • Bone Marrow Transplantation*
  • Follow-Up Studies
  • Humans
  • Phenotype
  • Time Factors
  • Transplantation, Homologous